Last reviewed · How we verify
Crystalloid based prime solution
At a glance
| Generic name | Crystalloid based prime solution |
|---|---|
| Sponsor | Vastra Gotaland Region |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion. (NA)
- Acute Kidney Injury After Cardiac Surgery (NA)
- Impact of Retrograde Autologous Priming on the Coagulation Profile Assessed by Rotation Thromboelastometry (ROTEM) in Patients Undergoing Cardiac Surgery (NA)
- Dextran-based Priming vs. Crystalloid and Mannitol-based Priming Solution in Adult Cardiac Surgery (PHASE2)
- Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Crystalloid based prime solution CI brief — competitive landscape report
- Crystalloid based prime solution updates RSS · CI watch RSS
- Vastra Gotaland Region portfolio CI